Slotnik Capital’s Verona Pharma VRNA Stock Holding History

Slotnik Capital’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-170,834	Closed	-$18.2M	–	49
2025 Q3	$18.2M	Buy	+170,834	New	+$17.8M	5.7%	6

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Slotnik Capital's VRNA Position: Q4 2025 in Review

Slotnik Capital sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 170,834 shares — an estimated $18.2M sold.

Slotnik Capital first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $18.2M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Slotnik Capital reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Slotnik Capital sold 170,834 Verona Pharma shares in Q4 2025, an estimated $18.2M.
Slotnik Capital first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Slotnik Capital's Verona Pharma position peaked at $18.2M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Slotnik Capital's 13F filing for Q4 2025, filed 13 Feb 2026.